XML 58 R42.htm IDEA: XBRL DOCUMENT v3.10.0.1
SHARE-BASED COMPENSATION (Tables)
12 Months Ended
Dec. 31, 2018
SHARE-BASED COMPENSATION  
Schedule of stock option activity

 

 

 

 

 

 

 

 

 

 

 

 

 

 

    

 

 

    

 

 

    

Weighted Average

    

Aggregate Intrinsic

 

 

 

 

 

 

Weighted Average

 

Remaining

 

Value

 

 

 

 

Options

 

Exercise Price

 

Contractual Term

 

(in thousands)

 

Outstanding as of December 31, 2017

 

 

67,188

 

$

24.65

 

3.39

 

 

 

 

Expired

 

 

(10,326)

 

 

77.47

 

 

 

 

 

 

Outstanding as of December 31, 2018

 

 

56,862

 

$

15.06

 

2.72

 

$

 —

 

Exercisable as of December 31, 2018

 

 

56,862

 

$

15.06

 

2.72

 

$

 —

 

 

Summary of information with respect to all outstanding and exercisable stock options

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Options Outstanding

 

 

Options Exercisable

 

 

 

 

    

 

    

 

 

    

Weighted Average

 

    

 

    

 

 

 

 

 

 

 

Number of options

 

Weighted Average

 

Remaining

 

 

Number

 

Weighted Average

 

Exercise Price or Range

 

outstanding

 

Exercise Price

 

Contractual Term

 

 

Exercisable

 

Exercise Price

 

$3.39

 - 

$13.50

 

49,039

 

$

6.47

 

2.99

 years

 

49,039

 

$

6.47

 

$54.40

 - 

$99.90

 

7,823

 

 

68.94

 

0.99

 years

 

7,823

 

 

68.94

 

 

 

 

 

56,862

 

$

15.06

 

2.72

 years

 

56,862

 

$

15.06

 

 

Schedule of RSU activity

 

 

 

 

 

 

 

 

 

 

 

 

    

Weighted Average

 

 

 

 

 

 

Grant-Date Fair Value

 

 

 

 

Number of Shares

 

Per Share

 

Unvested as of December 31, 2017

 

 

512,142

 

$

4.57

 

Granted

 

 

565,964

 

$

2.42

 

Vested

 

 

(202,713)

 

$

4.41

 

Forfeited

 

 

(69,549)

 

$

3.85

 

Unvested as of December 31, 2018

 

 

805,844

 

$

3.16

 

 

Schedule of share-based compensation expense, net of taxes withheld

 

 

 

 

 

 

 

 

 

 

 

 

For the Years Ended

 

 

 

 

December 31,

 

 

 

 

2018

    

2017

 

Share-based compensation expense:

 

 

 

 

 

 

 

 

Cost of sales

 

 

$

99

 

$

101

 

Selling, general and administrative

 

 

 

704

 

 

712

 

Net effect of share-based compensation expense on net income

 

 

$

803

 

$

813

 

Reduction in earnings per share:

 

 

 

 

 

 

 

 

Basic earnings per share

 

 

$

0.05

 

$

0.05

 

 

 

 

 

 

 

 

 

 

Diluted earnings per share

 

 

$

0.05

 

$

0.05

 


(1)

Income tax benefit is not illustrated because the Company is currently in a full tax valuation allowance position and an actual income tax benefit was not realized for the years ended December 31, 2018 and 2017. The result of the income (loss) situation creates a timing difference, resulting in a deferred tax asset, which is fully reserved for in the Company’s valuation allowance.